HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
MIRM
Mirum Pharmaceuticals Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $4.70B
Market Cap
$4.70B
Enterprise Val
$4.63B
P/E Ratio
-201.26
P/B Ratio
14.94
Trailing PEG (1Y)
2.67
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$314.7M
Gross Margin81.02%
Profit Margin81.02%
Return on Equity-8.53%
Return on Assets-3.07%
Current Ratio2.67
Debt/Equity1.01
LT Debt/Equity1.01
Revenue Per Share2.90

Income Statement

Dec 31, 2025
Revenue$148.9M
Cost of Revenue$28.3M
Gross Profit$120.7M
R&D$51.1M
SG&A$74.1M
Operating Expenses$125.2M
Operating Income-$4.6M
Interest Expense$3.6M
Tax Expense$767.0K
Net Income-$5.7M
EPS (Basic)$-0.12
EPS (Diluted)$-0.12
EBIT-$1.4M
EBITDA$5.2M
Consolidated Income-$5.7M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$298.2M
Accounts Receivable$123.3M
Inventory$24.9M
Current Assets$549.7M
LT Investments$8.1M
Property, Plant & Equipment$10.6M
Intangibles$260.9M
Non-Current Assets$293.1M
Total Assets$842.8M
Accounts Payable$9.6M
Current Debt$0.00
Current Liabilities$205.8M
LT Debt$317.3M
Non-Current Liabilities$322.3M
Total Liabilities$528.1M
Total Debt$317.3M
Retained Earnings-$667.5M
Shareholder Equity$314.7M
Shares Outstanding51,393,574

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$6.1M
Investing Cash Flow$1.0M
Financing Cash Flow$9.0M
CapEx-$600.0K
Free Cash Flow$5.5M
Depreciation & Amort.$6.5M
Stock-Based Comp$19.0M
Acquisitions / Disposals$0.00
Investment Activity$1.6M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$9.0M
Dividends Paid$0.00
Net Change in Cash$15.7M
Data cached · Meta live · Daily live · Statements live · TTL 24h